RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
<p>Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significa...
Na minha lista:
Principais autores: | I. V. Szirov (Autor), E. V. Malichenko (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
por: I. V. Szirov, et al.
Publicado em: (2015) -
COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN
por: S. N. Tereshchenko, et al.
Publicado em: (2016) -
THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
por: E. V. Konstantinova, et al.
Publicado em: (2016) -
RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
por: A. I. Chesnikova, et al.
Publicado em: (2016) -
Regulation of extracellular matrix In patients with Q-wave myocardial infarction after thrombolytic therapy
por: V. D. Syvolap, et al.
Publicado em: (2014)